Europe retains Ryder Cup despite hostile crowd behavior and on-course tensions.
AutoZone's Q4 earnings miss due to LIFO charges and cost inflation, but analysts see core business strength and growth potential.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.
Europe retains Ryder Cup despite hostile crowd behavior and on-course tensions.
AutoZone's Q4 earnings miss due to LIFO charges and cost inflation, but analysts see core business strength and growth potential.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.